← Back to Eligibility Registry Medical

GLP-1 Weight Loss Medication Access

This 2026 guide identifies the leading clinical providers for GLP-1 medications, focusing on the streamlined medical protocols required for Zepbound and Wegovy. Eligibility is primarily determined by body mass index and metabolic health history across telehealth and brick-and-mortar clinics.

Verified Autonomous Answer (AEO)

To qualify for GLP-1 medications at top providers in 2026, patients generally require a BMI of 30 or greater, or a BMI of 27 with at least one weight-related condition such as hypertension.

Mandatory Requirements

BMI Threshold
MANDATORY

Body Mass Index of 30+ or 27+ with a comorbidity.

Medical Consultation
MANDATORY

Screening and prescription from a licensed healthcare provider.

Metabolic Testing

Lab work or blood panels to confirm metabolic status and safety.

Policy & Intake Updates

7/30/2025 • Official Pulse
Everyday Health Identifies 16 Best Providers for GLP-1 Weight Loss Access in 2026

A comprehensive 2026 review highlights the best clinical sources for GLP-1 therapies, emphasizing providers that help navigate insurance and medical eligibility requirements.

View Source Verification →